HTL Biotechnology Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Private

  • Employees
  • 300

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

  • Investments
  • 3

HTL Biotechnology General Information

Description

Manufacturer and developer of hyaluronic acid (HA) and its by-products intended for the pharmaceutical, medical and cosmetics industries. The company specializes in the purification, research and development of Hyaluronan and produces other biological polymers, including chondroitin sulfate and heparosan, thereby enabling its clients to get raw materials for their production unit.

Contact Information

Website
www.htlbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 7 Rue Alfred Kastler
  • ZI de l'Aumaillerie
  • 35133 Javene
  • France
+33 02
Primary Industry
Specialty Chemicals
Vertical(s)
Manufacturing
Corporate Office
  • 7 Rue Alfred Kastler
  • ZI de l'Aumaillerie
  • 35133 Javene
  • France
+33 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HTL Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HTL Biotechnology‘s full profile, request access.

Request a free trial

HTL Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HTL Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HTL Biotechnology‘s full profile, request access.

Request a free trial

HTL Biotechnology Investments (3)

HTL Biotechnology’s most recent deal was a Seed Round with GelMEDIX for . The deal was made on 29-Apr-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GelMEDIX 29-Apr-2026 Seed Round Discovery Tools (Healthcare)
BIOPHTA 01-Jun-2024 Seed Round Drug Delivery
Modern Meadow (Beauty and Biomedical Division) 06-May-2024 Buyout/LBO Personal Products
To view HTL Biotechnology’s complete investments history, request access »

HTL Biotechnology FAQs

  • When was HTL Biotechnology founded?

    HTL Biotechnology was founded in 1992.

  • Where is HTL Biotechnology headquartered?

    HTL Biotechnology is headquartered in Javene, France.

  • What is the size of HTL Biotechnology?

    HTL Biotechnology has 300 total employees.

  • What industry is HTL Biotechnology in?

    HTL Biotechnology’s primary industry is Specialty Chemicals.

  • Is HTL Biotechnology a private or public company?

    HTL Biotechnology is a Private company.

  • What is the current valuation of HTL Biotechnology?

    The current valuation of HTL Biotechnology is .

  • What is HTL Biotechnology’s current revenue?

    The current revenue for HTL Biotechnology is .

  • Who are HTL Biotechnology’s investors?

    Montagu Private Equity, Partners Group, and Naxicap Partners have invested in HTL Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process